Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Pittman Scott M.
Over the trailing 90 days, Pittman Scott M. (Director at Nuo Therapeutics, Inc.) traded $210K of stock (net selling $3K) in AURX, per 9 SEC Form 4 transactions.
- Role
- Director
- Companies
- AURX
- Window
- Trailing 90 days · 9 transactions · CIK 1674752
- Net activity
- −$3K ($103K bought · $106K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| AURX | Nuo Therapeutics, Inc. | 9 | $103K | $106K | −$3K |
Transactions (9)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-30 | AURX | Buy | 40.0K | $40K | Exercise or conversion of derivative security |
| 2026-06-30 | AURX | Sell | 40.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-30 | AURX | Sell | 39.6K | $40K | Payment of exercise price or tax liability by delivering securities |
| 2026-06-29 | AURX | Buy | 30.0K | $0 | Grant, award or other acquisition |
| 2026-05-29 | AURX | Sell | 36.8K | $55K | Disposition to the issuer of issuer equity securities |
| 2026-05-29 | AURX | Buy | 17.4K | $26K | Grant, award or other acquisition |
| 2026-05-29 | AURX | Sell | 7.5K | $11K | Disposition to the issuer of issuer equity securities |
| 2026-05-29 | AURX | Buy | 17.5K | $26K | Grant, award or other acquisition |
| 2026-05-29 | AURX | Buy | 7.3K | $11K | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Pittman's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.